Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
